WA
BSX icon

Whipplewood Advisors’s Boston Scientific BSX Stock Holding History

Whipplewood Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.02K Sell
188
-493
-72% -$26.8K 0.01% 268
2026
Q1 		$42.7K Buy
681
+645
+1,792% +$51.6K 0.02% 283
2025
Q4 		$3.43K Buy
+36
New +$3.53K ﹤0.01% 320
2025
Q3 		– Sell
-989
Closed -$106K – 412
2025
Q2 		$106K Sell
989
-6
-0.6% -$607 0.06% 229
2025
Q1 		$100K Sell
995
-55
-5% -$5.54K 0.06% 222
2024
Q4 		$93.8K Buy
+1,050
New +$92.4K 0.05% 238

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Whipplewood Advisors's BSX Position: Q2 2026 in Review

Whipplewood Advisors reduced its Boston Scientific (BSX) stake by 72% in Q2 2026, selling an estimated $26.8K and leaving 188 shares worth $8.02K. The position accounts for 0.01% of the portfolio, ranked #268.

Whipplewood Advisors first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $106K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Whipplewood Advisors held 188 shares of Boston Scientific worth $8.02K as of Q2 2026.
  • Whipplewood Advisors sold 493 Boston Scientific shares in Q2 2026, an estimated $26.8K.
  • Boston Scientific made up 0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #268 holding.
  • Whipplewood Advisors first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • Whipplewood Advisors's Boston Scientific position peaked at $106K in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.